Fibronectin influences cellular proliferation and apoptosis similarly in LNCaP and PC-3 prostate cancer cell lines

Urologic Oncology

Volumn 5, Issue 4, 2000, Pages 155-159

  Morgan, Michael ^a   Saba, Sabiha ^a   Gower, William ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Apoptosis; Fibronectin; Proliferation; Prostate cancer

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 0034622421     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(99)00058-7     Document Type: Article

References (19)

1. Parker S.L., Tong T., Bolden S.et al. Cancer statistics, 1996. CA-Cancer J Clin. 65:1996;5-27.
2. Huggins C., Clark P.J. Studies on prostate cancer. The effect of castration on advanced carcinoma of the prostate. Arch Surg. 43:1941;209-233.
3. Isaacs W.B., Bova G.S., Morton R.A.et al. Molecular biology of prostate cancer. Semin Oncol. 21:1994;514-521.
4. Logothetis C.J., Hossien N.M., Hsieng J.T. The clinical and biologic study of androgen independent prostate cancer. Semin Oncol. 21:1994;620-629.
5. Davies P., Eaton C.L. Regulation of prostate growth. J Endocrinol. 131:1991;5-17.
6. Culig Z., Hobisch A., Cronaver M.V.et al. Androgen receptor activation in prostate tumor cell lines by insulin-like growth factor-1, keratinocytic growth factor, and epidermal growth factor. Cancer Res. 54:1994;5474-5478.
7. Kokontis J., Takatura K., Hay N.et al. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res. 54:1994;1566-1573.
8. Wolf D., Herzinger T., Hermilink H.et al. Transcriptional and posttranscriptional regulation of human androgen receptor by androgen. Mol Endocrinol. 7:1993;924-936.
9. Tilley W.D., Wilson C.M., Marcelli M.et al. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 50:1990;5382-5386.
10. Kyprianov N., Isaacs J.T. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology. 122:1988;552-562.
11. Isaacs J.T., Lundmo P.J., Beryes R.et al. Androgen regulation of programmed cell death of normal and malignant prostatic cells. J Androl. 13:1992;457-462.
12. Colombel M., Symmans F., Gil S.et al. Detection of the apoptosis suppressing oncoprotein Bcl-2 in hormone refractory human prostate cancer. Am J Pathol. 143:1993;390-400.
13. Raffo A., Perlman H., Chen M.et al. Overexpression of Bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vitro. Cancer Res. 55:1995;4438-4455.
14. Boudreu N., Sympson C.J., Werb Z.et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 267:1995;891-893.
15. Knox J.D., Cress A., Clark V.et al. Differential expression of extracellular matrix molecules and the alpha-6 integrins in normal and neoplastic prostate. Prostate. 23:1994;167-174.
16. Pullen S., Wilson J., Metcalf A.et al. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci. 109:1996;631-642.
17. Scott G., Cassidy L., Busacco A. Fibronectin suppresses apoptosis in normal human melanocytes through an integrin dependent mechanism. J Invest Dermatol. 108:1997;147-153.
18. Meredith J.E., Fazeli B., Schwartz M.A. The extracellular matrix as a survival factor. Mol Biol Cell. 4:1993;953-961.
19. Nagle R.B., Knox J.D., Wolf C.et al. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem. 19(suppl):1994;232-237.